Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT00328172. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy
ClinicalTrials.gov study NCT00638716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment
ClinicalTrials.gov study NCT01907113. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines
ClinicalTrials.gov study NCT02031679. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02924064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes
ClinicalTrials.gov study NCT00137046. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy
ClinicalTrials.gov study NCT02926937. IPD Sharing: NO. Countries: 3. Publications: 0.
A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01707147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00516048. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus
ClinicalTrials.gov study NCT02004678. IPD Sharing: YES. Countries: 1. Publications: 0.
A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics
ClinicalTrials.gov study NCT00886821. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
ClinicalTrials.gov study NCT01728116. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01406717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
ClinicalTrials.gov study NCT04002830. IPD Sharing: NO. Countries: 3. Publications: 0.
Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
ClinicalTrials.gov study NCT03386344. IPD Sharing: NO. Countries: 8. Publications: 0.
Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treat
ClinicalTrials.gov study NCT02068443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease
ClinicalTrials.gov study NCT01685216. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
ClinicalTrials.gov study NCT00736099. IPD Sharing: Not stated. Countries: 32. Publications: 0.
Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects
ClinicalTrials.gov study NCT03406377. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity
ClinicalTrials.gov study NCT01153815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.